Adverse Event Reports Rising Faster Than FDA Adds Surveillance Staff
This article was originally published in The Tan Sheet
Executive Summary
Adverse event reports submitted each year have quadrupled over the last decade, and FDA expects the reports to retain their value in ensuring product safety even as more technology helps with drug safety monitoring.